Farther Finance Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Sell
9,308
-1,025
-10% -$380K 0.03% 509
2026
Q1
$3.08M Buy
10,333
+1,726
+20% +$567K 0.03% 490
2025
Q4
$3.02M Buy
8,607
+4,517
+110% +$1.53M 0.03% 450
2025
Q3
$1.32M Buy
4,090
+1,414
+53% +$440K 0.02% 604
2025
Q2
$1.04M Sell
2,676
-134
-5% -$53.9K 0.02% 575
2025
Q1
$1.22M Buy
2,810
+653
+30% +$262K 0.03% 437
2024
Q4
$796K Buy
2,157
+634
+42% +$265K 0.03% 441
2024
Q3
$792K Buy
1,523
+317
+26% +$169K 0.03% 420
2024
Q2
$645K Buy
1,206
+160
+15% +$84.6K 0.03% 397
2024
Q1
$540K Buy
1,046
+102
+11% +$50.7K 0.03% 379
2023
Q4
$445K Buy
944
+321
+52% +$148K 0.03% 374
2023
Q3
$271K Buy
623
+262
+73% +$119K 0.04% 313
2023
Q2
$160K Sell
361
-10
-3% -$4.61K 0.04% 348
2023
Q1
$171K Buy
371
+29
+8% +$13.8K 0.05% 284
2022
Q4
$175K Buy
+342
New +$174K 0.07% 243

Other funds holding ELV

Farther Finance Advisors's ELV Position: Q2 2026 in Review

Farther Finance Advisors reduced its Elevance Health (ELV) stake by 9.9% in Q2 2026, selling an estimated $380K and leaving 9,308 shares worth $3.6M. The position accounts for 0.03% of the portfolio, ranked #509.

Farther Finance Advisors first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Farther Finance Advisors held 9,308 shares of Elevance Health worth $3.6M as of Q2 2026.
  • Farther Finance Advisors sold 1,025 Elevance Health shares in Q2 2026, an estimated $380K.
  • Elevance Health made up 0.03% of Farther Finance Advisors's portfolio in Q2 2026, its #509 holding.
  • Farther Finance Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.